Pseudopolyps are associated with increased fecal calprotectin levels in patients with Inflammatory Bowel Disease in clinical and endoscopic remission

被引：0
|
作者：
Spigarelli De Rabago, I. [1 ]
Suarez Ferrer, C. [2 ]
Poza Cordon, J. [2 ]
Martin Arranz, E. [2 ]
Sanchez Azofra, M. [2 ]
Rueda Garcia, J. L. [2 ]
Suarez Cabredo, C. G. [1 ]
Hernandez Perez, M. [1 ]
Martin Arranz, M. D. [2 ]
机构：
[1] La Paz Univ Hosp, Gastroenterol, Madrid, Spain
[2] Univ Autonoma Madrid, Hosp la Paz Inst Hlth Res, IdiPAZ La Paz Univ Hosp, Gastroenterol, Madrid, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.337
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P211
引用
收藏
页码：S270 / S271
页数：3
相关论文
共 50 条
  • [41] Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization
    Fukunaga, Shuhei
    Kuwaki, Kotaro
    Mitsuyama, Keiichi
    Takedatsu, Hidetoshi
    Yoshioka, Shinichiro
    Yamasaki, Hiroshi
    Yamauchi, Ryosuke
    Mori, Atsushi
    Kakuma, Tatsuyuki
    Tsuruta, Osamu
    Torimura, Takuji
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (01) : 107 - 118
  • [42] DETECTION OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE: FECAL AND SERUM LEVELS AND IMMONOHISTCHEMICAL LOCALIZATION
    Fukunaga, Shuhei
    Kuwaki, Kotaro
    Mitsuyama, Keiichi
    Takedatsu, Hidetoshi
    Yoshioka, Shinichiro
    Yamasaki, Hiroshi
    Yamauchi, Ryosuke
    Mori, Atsushi
    Tsuruta, Osamu
    Torimura, Takuji
    GASTROENTEROLOGY, 2017, 152 (05) : S769 - S770
  • [43] Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels
    Anssi Hmlinen
    Taina Sipponen
    Kaija-Leena Kolho
    World Journal of Gastroenterology, 2011, 17 (47) : 5166 - 5171
  • [44] Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels
    Hamalainen, Anssi
    Sipponen, Taina
    Kolho, Kaija-Leena
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (47) : 5166 - 5171
  • [45] Compliance With Fecal Calprotectin Testing in Pediatric Patients With Inflammatory Bowel Disease
    Queliza, Karen
    Wang, Michael K.
    Kellermayer, Richard
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 66 (06): : 932 - 933
  • [46] Correspondence: fecal calprotectin and cut-off levels in inflammatory bowel disease
    Kristensen, Vendel
    Moum, Bjorn
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (09) : 1183 - 1184
  • [47] Standardizing Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease
    Park, K. T.
    Heida, Anke
    van Rheenen, Patrick F.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (09) : E47 - E47
  • [48] Can fecal Calprotectin anticipate the future clinical activity in patients with quiescent Inflammatory Bowel Disease?
    Shah, Rushikesh
    Herrera, Henry
    Dewald, Rosemarie
    Swaroop, Prabhakar
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S40 - S41
  • [49] Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease
    Julsgaard, Mette
    Hvas, Christian L.
    Gearry, Richard B.
    Vestergaard, Thea
    Fallingborg, Jan
    Svenningsen, Lise
    Kjeldsen, Jens
    Sparrow, Miles P.
    Wildt, Signe
    Kelsen, Jens
    Bell, Sally J.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (07) : 1240 - 1246
  • [50] Fecal immunochemical test for hemoglobin versus fecal calprotectin to monitor endoscopic activity in inflammatory bowel disease
    Latorre, Patricia
    Torrente, Jorge
    Perez, Amparo
    Tenias, Jose Maria
    Moreno, Nadia
    Lopez-Serrano, Antonio
    Moreno-Osset, Eduardo
    Murado, Julian
    Paredes, Jose Maria
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2023, 115 (10) : 553 - 558
12345